Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 10, 2019
Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugsYaelle Bavli, Ilan Winkler, Bing Mae Chen, et al.
Plos One|February 24, 2025
PCR-based CRISPR/Cas9 system for fluorescent tagging: A tool for studying Candida parapsilosis virulenceTibor Nemeth, Andrea Zarnocki, Anett Ladanyi, et al.
Iranian Journal of Allergy, Asthma, and Immunology|September 4, 2017
Peptide-based Vaccines Derived from FcεRI Beta Subunit Can Reduce Allergic Response in Mice ModelAhad Zare, Ali Akbar Pourfathollah, Zahra Pourpak, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 3, 2010
Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell deathHila Epstein-Barash, Dikla Gutman, Ela Markovsky, et al.
Biochimica Et Biophysica Acta|June 16, 2004
Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levelsS Moein Moghimi, A Christy Hunter, Christopher M Dadswell, et al.
Shock (Augusta, Ga.)|September 23, 2003
Complement activation during hemorrhagic shock and resuscitation in swineJanos Szebeni, Lajos Baranyi, Sandor Savay, et al.
Journal of Liposome Research|October 1, 2005
Cerebrovascular involvement in liposome-induced cardiopulmonary distress in pigsMichael Bodo, Janos Szebeni, Lajos Baranyi, et al.
Advanced Drug Delivery Reviews|October 2, 2018
Animal models for analysis of immunological responses to nanomaterials: Challenges and considerationsWilliam C Zamboni, Janos Szebeni, Serguei V Kozlov, et al.
Advanced Drug Delivery Reviews|December 13, 2021
To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternativesDa Shi, Damian Beasock, Adam Fessler, et al.
Biomaterials|April 5, 2011
In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymersOlivia M Merkel, Rudolf Urbanics, Peter Bedocs, et al.
Pageof 5